Biocartis
Randy Polonsky currently serves as the Chief Financial Officer at Biocartis, a position held since November 2024. Prior to this role, Randy was the Vice President of Financial Planning & Analysis at Talis Biomedical Corporation from November 2021 to November 2024, where significant achievements included introducing an automated financial reporting package and overseeing budget and forecast processes. Randy also held the position of Financial Planning and Analysis Director at Vyaire Medical, driving financial performance through comprehensive planning and cross-functional collaboration from September 2017 to November 2021. Earlier experience includes key financial management roles at CDW, PepsiCo, and Sears Holdings Corporation, along with leadership in financial planning and analysis, strategic development, and compliance efforts at various organizations. Randy earned an MBA in Finance from DePaul Driehaus College of Business and a BBA in Accounting from Wisconsin School of Business.
This person is not in any teams
This person is not in any offices
Biocartis
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.